Reported Earnings • May 07
First quarter 2026 earnings released: US$0.14 loss per share (vs US$0.30 loss in 1Q 2025) First quarter 2026 results: US$0.14 loss per share (improved from US$0.30 loss in 1Q 2025). Revenue: US$123.6m (up 6.7% from 1Q 2025). Net loss: US$4.15m (loss narrowed 51% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 40 percentage points per year, which is a significant difference in performance. Announcement • May 04
American Vanguard Corporation to Report Q1, 2026 Results on May 06, 2026 American Vanguard Corporation announced that they will report Q1, 2026 results After-Market on May 06, 2026 Announcement • Apr 24
American Vanguard Corporation, Annual General Meeting, Jun 03, 2026 American Vanguard Corporation, Annual General Meeting, Jun 03, 2026. New Risk • Mar 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$25m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (US$58.8m market cap). New Risk • Mar 18
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$99.9m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$25m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risk Market cap is less than US$100m (US$99.9m market cap). Reported Earnings • Mar 18
Full year 2025 earnings released: US$1.76 loss per share (vs US$4.50 loss in FY 2024) Full year 2025 results: US$1.76 loss per share (improved from US$4.50 loss in FY 2024). Revenue: US$515.1m (down 5.9% from FY 2024). Net loss: US$49.9m (loss narrowed 61% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance. Announcement • Mar 14
American Vanguard Corporation to Report Fiscal Year 2025 Results on Mar 16, 2026 American Vanguard Corporation announced that they will report fiscal year 2025 results After-Market on Mar 16, 2026 New Risk • Nov 20
New major risk - Revenue and earnings growth Earnings have declined by 74% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 74% per year over the past 5 years. Reported Earnings • Nov 11
Third quarter 2025 earnings: EPS and revenues miss analyst expectations Third quarter 2025 results: US$0.43 loss per share (improved from US$0.91 loss in 3Q 2024). Revenue: US$119.3m (flat on 3Q 2024). Net loss: US$12.4m (loss narrowed 52% from 3Q 2024). Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 3.6% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Announcement • Nov 11
American Vanguard Corporation Updates Earnings Guidance for the Year 2025 American Vanguard Corporation updated earnings guidance for the year 2025. The company have lowered forecast for net sales to $520 million to $535 million in 2025 to reflect various market conditions, primarily in Mexico, Central America and Australia. New Risk • Nov 11
New major risk - Revenue and earnings growth Earnings have declined by 76% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.1% operating cash flow to total debt). Earnings have declined by 76% per year over the past 5 years. Announcement • Nov 06
American Vanguard Corporation to Report Q3, 2025 Results on Nov 10, 2025 American Vanguard Corporation announced that they will report Q3, 2025 results Pre-Market on Nov 10, 2025 New Risk • Aug 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.1% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Price Target Changed • Aug 12
Price target decreased by 14% to US$12.00 Down from US$14.00, the current price target is provided by 1 analyst. New target price is 135% above last closing price of US$5.10. Stock is down 9.4% over the past year. The company is forecast to post a net loss per share of US$0.13 next year compared to a net loss per share of US$4.50 last year. Announcement • Jul 30
American Vanguard Corporation to Report Q2, 2025 Results on Jul 31, 2025 American Vanguard Corporation announced that they will report Q2, 2025 results After-Market on Jul 31, 2025 Announcement • May 30
American Vanguard Corporation, Annual General Meeting, Jul 02, 2025 American Vanguard Corporation, Annual General Meeting, Jul 02, 2025. Announcement • May 13
American Vanguard Corporation announced delayed 10-Q filing On 05/12/2025, American Vanguard Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Announcement • Apr 06
American Vanguard Receives NYSE Notice Regarding Delayed 10-K Filing On April 2, 2025, American Vanguard Corporation received notice from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”). The Company determined it would not be able to file the Form 10-K within the 15-day extension period under Rule 12b-25 and needs additional time, resources and effort to complete its year-end reporting process. Accordingly, the Company is working diligently to complete the necessary work to make the filing as soon as possible. The Company can regain compliance with listing standards by completing the filing and expects its common stock to continue to be listed on the NYSE as it completes the Form 10-K. Announcement • Feb 28
American Vanguard Corporation to Report Q4, 2024 Results on Mar 14, 2025 American Vanguard Corporation announced that they will report Q4, 2024 results Pre-Market on Mar 14, 2025 Announcement • Dec 13
American Vanguard Corporation Announces Changes to its Board American Vanguard Corporation announced that Debra Edwards is retiring from the board of directors and has therefore resigned. Ms. Edwards has been on the Board since 2011, having served as Chair of the Compensation Committee, as well as on the Risk and Finance Committees. To fill the vacancy left by Ms. Edwards’ retirement, the Board appointed Carmen Tiu, effective December 11, 2024. Ms. Tiu will serve on the Risk and Finance Committees. She has extensive experience in the agriculture industry, having joined Dow AgroSciences in 1987 and served at its successor company Corteva AgroSciences in roles of increasing responsibility until earlier this year, primarily in regulatory strategy, food standards, risk, and government affairs. Announcement • Dec 05
American Vanguard Corporation Appoints Douglas A. Kaye, III as Chief Executive Officer American Vanguard Corporation announced the appointment of Douglas A. Kaye, III as the new Chief Executive Officer following a unanimous vote from its Board of Directors, effective December 9, 2024. Mr. Kaye will be based at global headquarters beginning January 6, 2025. Mr. Kaye brings extensive experience to AVD and is expected to lead the Company into a new era of growth and innovation. He will succeed the Office of CEO (OCEO), which has been in place since July 15, 2024. Dak’s global agricultural knowledge will be valuable in leading the Company. For the past 13 years, he has served in a variety of senior leadership roles at Albaugh, LLC, a top ten global crop protection company. He most recently held the role of President, North America, which is the largest region in the Company. Previously, he was Group Chief Commercial Officer, where he oversaw the commercial activities, which included North America, Europe, Brazil, Argentina, and Latin America regions. Mr. Kaye also served as President of the European region for seven years. Prior to his work at Albaugh, Dak was the CFO and a Director at a non-crop subsidiary of the crop protection company, Adama, and previously held the role of Co-CEO at an international automotive logistics organization. Mr. Kaye began his career at Arthur Andersen, LLP. He has a Masters of Accountancy and a Bachelor of Science in Business Administration, both from Auburn University. Mr. Kaye was recently elected to the Executive Board of the industry group CropLife America (CLA). Recent Insider Transactions • Nov 20
Independent Director recently bought US$72k worth of stock On the 15th of November, Steven Macicek bought around 12k shares on-market at roughly US$5.97 per share. This transaction amounted to 62% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold US$165k more in shares than they bought in the last 12 months. Reported Earnings • Nov 12
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: US$0.92 loss per share (further deteriorated from US$0.012 loss in 3Q 2023). Revenue: US$118.3m (down 21% from 3Q 2023). Net loss: US$25.7m (loss widened US$25.4m from 3Q 2023). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 5.8% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 46 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Sep 05
Chairman recently sold US$572k worth of stock On the 30th of August, Eric Wintemute sold around 100k shares on-market at roughly US$5.72 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Eric's only on-market trade for the last 12 months. Announcement • Aug 21
American Vanguard Corporation Withdraws Dacthal Registration American Vanguard Corporation announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, the Company has submitted to the Environmental Protection Agency (“EPA”) voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6, 2024. In connection with its action, the Company made the following statements. While the Company continues to question EPA’s conclusions in support of the suspension, it believe that the best course of action is to voluntarily cancel registrations of this product. The company is working apace with both state and federal authorities to effect product return and to remove Dacthal from channels of distribution. It is the Company’s position that product stewardship be international in scope; thus, it will now proceed to voluntarily cancel all international registrations as well. It is important to note that EPA’s findings are based upon the test results of a single, relatively new study that the Company had provided to the agency over two years ago which showed an effect on fetal rodents at certain dose levels. As is typically the case with such studies, the observed effect was extrapolated to indicate a potential effect upon human beings. The suspension order, then, was issued by EPA on the premise of preventing potential harm, rather than in response to an actual, reported harm. The Company had been working with the EPA in good faith for over one year to identify risk mitigation measures that might alleviate concerns and allow continued use of high-benefit use patterns. However, these measures apparently did not give the EPA sufficient certainty at the time. The Company was also discussing with the EPA the potential for completion of additional toxicology and exposure studies that may have alleviated risk concerns, had they been afforded time to proceed. The Company nevertheless thanks EPA for expending time and resources to consider and evaluate the many proposed risk mitigation measures. New Risk • Aug 12
New major risk - Revenue and earnings growth Earnings have declined by 9.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 9.1% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (12% average weekly change). New Risk • Aug 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (9.9% average weekly change). Announcement • Aug 09
American Vanguard Corporation Lowers Earnings Guidance for the Full Year 2024 American Vanguard Corporation lowered earnings guidance for the full year 2024. For the year, the company expects net sales to be down 2%-to-flat (compared to previous estimate of sales up 6% to 9%) or $565 million to $580 million. New Risk • Aug 07
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (1.2% net profit margin). Valuation Update With 7 Day Price Move • Aug 07
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to US$7.87, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 15x in the Chemicals industry in the US. Total loss to shareholders of 48% over the past three years. Announcement • Aug 07
American Vanguard Corporation to Report Q2, 2024 Results on Aug 08, 2024 American Vanguard Corporation announced that they will report Q2, 2024 results at 4:00 PM, US Eastern Standard Time on Aug 08, 2024 Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to US$9.51, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in the US. Total loss to shareholders of 43% over the past three years. Announcement • Jul 08
American Vanguard Corporation Announces Retirement of Eric G. Wintemute as CEO American Vanguard Corporation reported that its Chairman and Chief Executive Officer, Eric G. Wintemute, has presented to the board his plan to retire from his position as CEO. The terms of his retirement are set forth in a Transition Agreement under which Mr. Wintemute will participate in the search for his successor being conducted by the global executive search firm, Kincannon & Reed, and retire upon the successor’s appointment but no later than December 31, 2024. Mr. Wintemute will continue to serve as Chairman of the Board and, post-retirement, will provide consulting services to the company on a part-time basis. Mr. Wintemute joined the company 47 years ago and has served as CEO for 30 years. Mr. Wintemute successfully led the growth of this organization over those 30 years, and due to his vision and guidance, American Vanguard has become a multi-faceted, global platform, serving hundreds of companies around the world. Announcement • Jul 03
American Vanguard Corporation(NYSE:AVD) dropped from Russell 2000 Growth-Defensive Index American Vanguard Corporation(NYSE:AVD) dropped from Russell 2000 Growth-Defensive Index Upcoming Dividend • Jun 19
Upcoming dividend of US$0.03 per share Eligible shareholders must have bought the stock before 26 June 2024. Payment date: 10 July 2024. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 1.4%. Lower than top quartile of American dividend payers (4.8%). Lower than average of industry peers (1.9%). Board Change • Jun 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Steven Macicek was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • May 30
American Vanguard Announces the Retirement of Bob Trogele as Executive Vice President & Chief Operating Officer, Effective May 31, 2024 American Vanguard Corporation announced that, after 35 years in the agrochemical industry, Executive Vice President & Chief Operating Officer, Bob Trogele, will be retiring effective May 31, 2024. Mr. Trogele joined the company’s principal operating subsidiary, AMVAC, in January 2015 to focus on growing the business across multiple product lines and geographies, achieving greater profitability, and establishing a pipeline of future opportunities through innovation and strategic relationships. Following his retirement, Mr. Trogele plans to remain involved in global agribusiness as an independent board director, investor and entrepreneur. Announcement • May 11
American Vanguard Corporation Provides Earnings Guidance for the Year 2024 American Vanguard Corporation provided earnings guidance for the year 2024. For the year, the company adjusts annual targets to achieve an increase in net sales of between 6% and 9% year over year. Announcement • May 09
American Vanguard Corporation to Report Q1, 2024 Results on May 09, 2024 American Vanguard Corporation announced that they will report Q1, 2024 results After-Market on May 09, 2024 Announcement • Mar 29
American Vanguard Corporation, Annual General Meeting, Jun 06, 2024 American Vanguard Corporation, Annual General Meeting, Jun 06, 2024, at 11:00 Pacific Standard Time. Agenda: To nominate directors; to ratify Deloitte & Touche LLP as independent public registered accounting firm for the year ending December 31, 2024; and to decide on executive compensation. Announcement • Mar 16
American Vanguard Corporation announced delayed annual 10-K filing On 03/15/2024, American Vanguard Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC. Price Target Changed • Mar 15
Price target increased by 13% to US$17.50 Up from US$15.50, the current price target is an average from 2 analysts. New target price is 36% above last closing price of US$12.90. Stock is down 39% over the past year. The company is forecast to post earnings per share of US$0.77 for next year compared to US$0.27 last year. Announcement • Mar 15
American Vanguard Corporation Provides Financial Guidance for the Year 2024 American Vanguard Corporation provided financial guidance for the year 2024. For the year, the company is targeting 8% to 12% revenue growth. Declared Dividend • Mar 13
Third quarter dividend of US$0.03 announced Dividend of US$0.03 is the same as last year. Ex-date: 26th March 2024 Payment date: 10th April 2024 Dividend yield will be 1.1%, which is lower than the industry average of 2.0%. Sustainability & Growth Dividend is covered by earnings (76% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 176% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Announcement • Mar 12
American Vanguard Corporation to Report Q4, 2023 Results on Mar 14, 2024 American Vanguard Corporation announced that they will report Q4, 2023 results After-Market on Mar 14, 2024 Announcement • Mar 11
American Vanguard Declares Quarterly Cash Dividend, Payable on April 10, 2024 American Vanguard Corporation announced that its Board of Directors has declared a cash dividend in the amount of $0.03 per share of the company’s common stock to shareholders of record as of March 27, 2024, for distribution on April 10, 2024. Announcement • Mar 08
American Vanguard Corporation Announces Board Changes American Vanguard Corporation announced that Mort Erlich, who has served on the company’s board of directors since October 2013, has expressed his intention to retire effective as of the filing of the Form 10-K for the period ended December 31, 2023. Mr. Erlich joined American Vanguard after a 34-year career with KPMG LLP and has served as the Chair of the company’s Audit Committee, as well as a member of both the Compensation Committee and Nominating & Corporate Governance Committee. In light of Mr. Erlich’s retirement, the company’s board has appointed Steven Macicek to succeed Mr. Erlich as Chair of its Audit Committee. Mr. Macicek formerly served as Global Client Services Partner at Ernst & Young, where he was a member of the firm’s Center for Board Matters, gaining expertise in corporate governance and addressing boardroom issues. An accomplished auditor and business advisor, Mr. Macicek has served numerous high-growth national and large-scale multinational corporations in a wide range of sectors and was relied upon for his broad knowledge of accounting, finance, risk management, M&A, executive leadership, governance, and international business. Announcement • Jan 25
American Vanguard Corporation to Report Q4, 2023 Results on Jan 31, 2024 American Vanguard Corporation announced that they will report Q4, 2023 results on Jan 31, 2024 Upcoming Dividend • Dec 21
Upcoming dividend of US$0.03 per share at 1.1% yield Eligible shareholders must have bought the stock before 28 December 2023. Payment date: 12 January 2024. Payout ratio is on the higher end at 76% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of American dividend payers (4.6%). Lower than average of industry peers (2.0%). Announcement • Dec 15
American Vanguard Corporation Declares Quarterly Cash Dividend, Payable on January 12, 2024 American Vanguard Corporation announced that its Board of Directors has declared a cash dividend in the amount of $0.03 per share of the company’s common stock to shareholders of record as of December 29, 2023, for distribution on January 12, 2024. Recent Insider Transactions • Dec 14
COO & Executive VP recently bought US$75k worth of stock On the 11th of December, Ulrich Trogele bought around 8k shares on-market at roughly US$10.00 per share. This transaction amounted to 4.2% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$97k. Ulrich has been a buyer over the last 12 months, purchasing a net total of US$172k worth in shares. Announcement • Dec 04
American Vanguard Corporation Hires Don Gualdoni as Chief Transformation Officer American Vanguard Corporation announced that it has hired Don Gualdoni to the newly-created position of chief transformation officer. Mr. Gualdoni brings to this assignment over 25 years’ experience in various leadership roles during which he has led several large, complex transformation projects. He joins the company most recently from Teradata and was formerly with McKinsey & Company. Mr. Gualdoni has a BSE in Chemical Engineering from the University of Michigan and an MBA from the Kellogg School of Management at Northwestern University. Recent Insider Transactions • Nov 22
COO & Executive VP recently bought US$97k worth of stock On the 17th of November, Ulrich Trogele bought around 11k shares on-market at roughly US$8.99 per share. This transaction amounted to 6.4% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Ulrich's only on-market trade for the last 12 months. New Risk • Nov 14
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: US$91k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risks Profit margins are more than 30% lower than last year (0.8% net profit margin). Significant insider selling over the past 3 months (US$91k sold). Announcement • Nov 12
American Vanguard Corporation Provides Earnings Guidance for the Fourth Quarter of 2023 and for the Year 2024 American Vanguard Corporation provided earnings guidance for the fourth quarter of 2023 and for the year 2024. The company anticipated improved sales and profitability in the fourth quarter as compared to the first nine months of this fiscal year.For 2024, the company is targeting 8% - 12% growth in sales and 25% - 35% growth in adjusted EBITDA for the full year 2024. Reported Earnings • Nov 10
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Third quarter 2023 results: US$0.012 loss per share (down from US$0.23 profit in 3Q 2022). Revenue: US$149.5m (down 1.7% from 3Q 2022). Net loss: US$325.0k (down 105% from profit in 3Q 2022). Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Announcement • Nov 03
American Vanguard Corporation Announces Appointment Shirin Khosravi as Senior Vice President of Human Resources American Vanguard Corporation announced that it has hired Ms. Shirin Khosravi to the newly-created position of Senior Vice President of Human Resources. Ms. Khosravi brings to this assignment over 30 years of progressive international HR experience in multiple Fortune 500 companies. In those roles, she has demonstrated extensive accomplishments in talent management, succession planning, employee engagement, process standardization and large-scale transformation and change management. She has considerable experience aligning people programs to business strategy with a passion for DEI and high-performance culture. Ms. Khosravi holds a Bachelor of Business Degree from the Edith Cowan University in Australia and Executive MBA from Western University’s Ivey Business School in Canada. Announcement • Nov 01
American Vanguard Corporation to Report Q3, 2023 Results on Nov 08, 2023 American Vanguard Corporation announced that they will report Q3, 2023 results After-Market on Nov 08, 2023 Price Target Changed • Oct 18
Price target decreased by 15% to US$23.50 Down from US$27.50, the current price target is an average from 2 analysts. New target price is 129% above last closing price of US$10.26. Stock is down 56% over the past year. The company is forecast to post earnings per share of US$1.04 for next year compared to US$0.94 last year. Announcement • Sep 13
American Vanguard Corporation Declares Cash Dividend, Payable on October 6, 2023 American Vanguard Corporation announced that its Board of Directors has declared a cash dividend in the amount of $0.03 per share of the company’s common stock to shareholders of record as of September 22, 2023, for distribution on October 6, 2023. Recent Insider Transactions • Aug 17
Independent Director recently bought US$225k worth of stock On the 14th of August, Patrick Gottschalk bought around 15k shares on-market at roughly US$14.97 per share. This transaction amounted to 40% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$608k more in shares than they have sold in the last 12 months. New Risk • Aug 09
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 4.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 09
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Second quarter 2023 results: US$0.037 loss per share (down from US$0.23 profit in 2Q 2022). Revenue: US$132.8m (down 10% from 2Q 2022). Net loss: US$1.05m (down 115% from profit in 2Q 2022). Revenue missed analyst estimates by 19%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Announcement • Aug 03
American Vanguard Corporation to Report Q2, 2023 Results on Aug 08, 2023 American Vanguard Corporation announced that they will report Q2, 2023 results After-Market on Aug 08, 2023 Upcoming Dividend • Jun 20
Upcoming dividend of US$0.03 per share at 0.7% yield Eligible shareholders must have bought the stock before 27 June 2023. Payment date: 14 July 2023. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of American dividend payers (4.9%). Lower than average of industry peers (2.4%). Announcement • Jun 13
American Vanguard Corporation Declares Cash Dividend, Payable on July 14, 2023 American Vanguard Corporation announced that at a meeting of the Company’s board of directors that was held on June 8, 2023, the board declared a cash dividend in the amount of $0.03 per share to holders of the Company’s common stock as of June 28, 2023, for distribution on July 14, 2023. Announcement • May 26
American Vanguard Corporation (NYSE:AVD) announces an Equity Buyback for $15 million worth of its shares. American Vanguard Corporation (NYSE:AVD) announces a share repurchase program. Under the program, the company will repurchase up to $15 million worth of its common stock. The program will be valid over the next twelve months. Major Estimate Revision • May 19
Consensus EPS estimates fall by 13% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$657.7m to US$643.2m. EPS estimate also fell from US$1.19 per share to US$1.04 per share. Net income forecast to grow 69% next year vs 16% growth forecast for Chemicals industry in the US. Consensus price target of US$29.50 unchanged from last update. Share price rose 6.2% to US$17.65 over the past week. 